Filer Snapshot

AngioGenex, Inc. SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0001085596.

Entity Type

Company

Total Filings

161

Latest Filing

10 Mar 2023

Industry

Pharmaceutical Preparations

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

  • Use the filings table to verify the newest submission, form type, and report period.
  • Open the deeper context page only when this filer actually has insider or ownership signal.
Go to latest filings table Open insider trading context
Source: SEC filing REVOKED

REVOKED filed on 10 Mar 2023 for CIK 0001085596.

View Source Filing
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
425 Madison Avenue, Suite 902, New York, NY, 10017
State of incorporation
NV
Fiscal year end
31 December
Former names
ECLIC INC/NV (to 05 Jan 2006)

Key facts

  • AngioGenex, Inc. is an SEC filer tracked under CIK 0001085596.
  • 161 filings are listed on this profile.
  • Common form coverage includes REVOKED, 5, D and more.

Change

  • Latest filing: REVOKED filed on 10 Mar 2023.
  • Report period: not specified in filing header.

Research use

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Evidence

Source: SEC filing REVOKED

REVOKED filed on 10 Mar 2023 for CIK 0001085596.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed REVOKED can change the filing history, ownership context, or next research path for AngioGenex, Inc..

Latest source-backed update
REVOKED filed 10 Mar 2023
Why come back
Revisit after a new SEC filing appears to compare the updated record with prior filings.
  • Latest filing on record: REVOKED filed 10 Mar 2023.
  • Save this filer if you want a stable place to return after the next filing cycle.
  • Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Jump to save and follow actions Open latest filings table

Company intelligence

AngioGenex, Inc.: filings, ownership, insiders

CIK 0001085596. Open the active data lane, then verify the SEC filing behind the row.

Create free account to watch this company Open ownership signals

Active modules

2/5

Available company intelligence paths on this page.

Filings

161

SEC submissions provide the evidence trail.

Ownership context

1/3

Insider, large-stake, and institutional ownership lanes.

Return loop

Watch

Return when a new SEC-backed change lands.

Research checks

Latest filing

REVOKED filed 10 Mar 2023

Ownership lanes

1/3 active

CIK

0001085596

Next review

watch new filing, insider, 13D/G, or 13F change

SEC-verifiable company research path

Keep the next click tied to one changing object: a CIK, filing, insider, Schedule 13D/G holder, Form 13F manager, or security.

Open latest insider signals Open large-stake radar

SEC filings

Available

Latest company filings

Start with the filing timeline to verify the newest source document and report period.

Open filings table

Company facts

Explore

Financial context

Use XBRL facts when ownership activity needs revenue, earnings, debt, or cash-flow context.

Browse latest financial reports

Forms 3/4/5

Available

Insider activity

Check whether directors, officers, or 10% owners are buying, selling, or filing fresh ownership changes.

Open insider activity

Schedule 13D/G

Explore

Large-stake holders

Review beneficial ownership filings for activist-style or passive large holder changes around this issuer.

Browse large-stake radar

Form 13F

Explore

Institutional holders

Compare manager filings and smart-money context when company-level ownership needs broader holders.

Browse smart-money dashboard

SEC-verifiable company hub

Filings first, then ownership signals, insider context, and fundamentals.

Create free account to watch this company

Watchlist return triggers

Watch AngioGenex, Inc. when any filing-backed ownership signal appears, then jump back into the exact SEC evidence path.

new company filing insider Form 4 13D/G holder change 13F holder update

Filer Overview

AngioGenex, Inc. has filed 161 SEC EDGAR filings since 24 May 1999. Common forms include REVOKED, 5, D, 8-K and more.

AngioGenex, Inc. SEC filings AngioGenex, Inc. insider transactions

Latest Filings

Recent SEC filings for AngioGenex, Inc. with direct links to document and filing folders.

REVOKED File 000-26181

REVOKED filing

Filing date
10 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
17 Feb 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
16 Feb 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
16 Feb 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
15 Feb 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-425689

D filing

Filing date
17 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26181

AGGX 8-K 12/15/21

Filing date
16 Dec 2021
Reporting date
09 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
13 Jul 2020
Reporting date
30 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26181

AGGX 8-K 07/10/20

Filing date
13 Jul 2020
Reporting date
30 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26181

AGGX 8-K 02/11/20

Filing date
11 Feb 2020
Reporting date
28 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26181

AGGX 8-K 09/13/19

Filing date
13 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-26181

AGGX 10-Q 06/30/19

Filing date
14 Aug 2019
Reporting date
30 Jun 2019
Next action
Verify source filing
10-Q File 000-26181

AGGX 10-Q 03/31/19

Filing date
20 May 2019
Reporting date
31 Mar 2019
Next action
Verify source filing
NT 10-Q File 000-26181

AGGX NT10-Q 03/31/19

Filing date
15 May 2019
Reporting date
31 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-26181

AGGX DEF14A 04/01/19

Filing date
01 Apr 2019
Reporting date
01 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-26181

AGGX 10-K 12/31/18

Filing date
28 Mar 2019
Reporting date
31 Dec 2018
Next action
Verify source filing
4

4 filing

Filing date
04 Feb 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-26181

AGGX 10-Q 09/30/18

Filing date
13 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
10-Q File 000-26181

AGGX 10-Q 06/30/18

Filing date
14 Aug 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
DEF 14A File 000-26181

AGGX DEF 14A 07/06/18

Filing date
06 Jul 2018
Reporting date
06 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-26181

AGGX 10-Q 03/31/18

Filing date
14 May 2018
Reporting date
31 Mar 2018
Next action
Verify source filing
10-K File 000-26181

AGGX 10-K 12/31/17

Filing date
02 Apr 2018
Reporting date
31 Dec 2017
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
23 Jan 2018
Reporting date
30 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26181

AGGX 8-K 12/05/17

Filing date
05 Dec 2017
Reporting date
28 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-26181

AGGX DEF14A 11/30/17

Filing date
01 Dec 2017
Reporting date
30 Nov 2007
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-26181

AGGX 10-Q 09/30/17

Filing date
14 Nov 2017
Reporting date
30 Sep 2017
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
11 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
29 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-12G/A File 000-26181

AGGX FORM10-12G/A2 09/29/17 RED

Filing date
29 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
26 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
19 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-12G/A File 000-26181

AGGX FORM 10-12G/A1 09/19/17

Filing date
19 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
05 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-12G File 000-26181

AGGX FORM 10-12G 08/22/17

Filing date
22 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
RW File 000-26181

AGGX RW 08/22/17

Filing date
22 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
25 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-12G File 000-26181

AGGX FORM 10-12G 06/27/17

Filing date
28 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26181

AGGX 8-K 04/10/17

Filing date
10 Apr 2017
Reporting date
05 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
15-12G File 000-26181

ANGIOGENEX, INC. FORM 15 12 G 04/13/10

Filing date
13 Apr 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 000-26181

AGGX NT 10-K 012-31-09

Filing date
31 Mar 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
5

PRIMARY DOCUMENT

Filing date
08 Jan 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
5

PRIMARY DOCUMENT

Filing date
08 Jan 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
5

PRIMARY DOCUMENT

Filing date
08 Jan 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
5

PRIMARY DOCUMENT

Filing date
08 Jan 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing

About this filer

AngioGenex, Inc. files with the SEC under CIK 0001085596. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .